Request for information invites feedback on disposal products to help reduce misuse of unused medications. The U.S. Food and Drug Administration (FDA) has issued a Request for Information…
Read MorePrescriptions
White House Launches Prescription Drug Pricing Platform
The website offers cash-price discounts on select medications. The White House announced the launch of TrumpRx, an online platform intended to provide lower cash prices on certain commonly…
Read MorePresident Proposes Affordable Health Plan to Congress
Multiple avenues presented, the proposal seeks to lower costs and hold insurance companies accountable. President Donald Trump has announced the “Great Healthcare Plan,” which focuses on increasing healthcare…
Read More
Senate Committee Seeks FDA Safeguards on Abortion Pills
The legislators urge in-person dispensing of mifepristone, citing the black box warnings. Members of the Senate Committee on Health, Labor, Education, and Pensions are calling on the Food…
Read More
HHS and DEA Extend Telemedicine Prescribing Flexibilities Through 2026
Temporary extension maintains access to certain controlled medications. The Department of Health and Human Services (HHS), in coordination with the Drug Enforcement Administration (DEA), announced a fourth temporary…
Read More
President Trump Announces Lower Prescription Drug Pricing
The president has persuaded U.S.-based companies to take action. President Donald Trump recently struck a deal with nine U.S. pharmaceutical companies, which will decrease prices for a large…
Read More
FDA Adds Warning and Restrictions to Duchenne Gene Therapy
Updated labeling limits treatment to ambulatory children after reports of fatal liver failure in non-ambulatory patients. The U.S. Food and Drug Administration (FDA) has approved significant labeling changes…
Read More
HHS and FDA to Require Full Safety Disclosures in Drug Ads
Secretary Kennedy denounces pharmaceutical ads but does not advocate for ban. The Food and Drug Administration (FDA) began the process last week of rescinding a 1997 policy that…
Read More
FDA Approves Immunotherapy Treatment for Adult Respiratory Papillomatosis
Final reports from Precigen showed long-term effectiveness of the injections with reduced side effects. The Food and Drug Administration (FDA) has approved a drug manufactured by Precigen to…
Read More
FDA Updates Opioid Labels to Emphasize Long-Term Risks
New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The U.S. Food and Drug Administration (FDA) has mandated updated safety…
Read More